Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    -0.65 (-3.23%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €111.86b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

BBVA's share capital reduction

23 Dec 2025 17:28

RNS Number : 7265M
Banco Bilbao Vizcaya Argentaria SA
23 December 2025
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Company"), in compliance with the securities market legislation, hereby communicates the following:

 

OTHER RELEVANT INFORMATION

 

Notice is hereby given of the partial execution of the share capital reduction resolution adopted by the Ordinary General Shareholders' Meeting of BBVA held on 21 March 2025, under agenda item three, through the reduction of BBVA's share capital in a nominal amount of 26,615,214.85 euros, by means of the cancellation of 54,316,765 own shares of 0.49 euros par value each held by the Company as treasury shares.

 

The own shares subject to the cancellation were acquired derivatively by the Company in execution of the program for the repurchase of own shares, which was communicated by means of inside information dated 30 October 2025 (registration number 2,966). The completion of the program for the repurchase of own shares was communicated by BBVA as other relevant information on 10 December 2025 (registration number 38,097).

 

Following the cancellation of the 54,316,765 own shares with a par value of 26,615,214.85 euros, BBVA's share capital has been set at 2,797,394,663 euros, represented by 5,708,968,700 shares with a par value of 0.49 euros each.

 

This capital reduction does not entail the return of contributions, since the Company itself is the owner of the redeemed shares, and is charged to unrestricted reserves, through the allocation of the reserve for redeemed capital for an amount equal to the par value of the redeemed shares, which can only be used under the same conditions as those required for the reduction of the share capital, in application of the provisions of Article 335 c) of the Spanish Companies Act. Consequently, the Company's creditors will not have the right of opposition referred to in Article 334 of the Spanish Companies Act.

 

Likewise, notice is hereby given that BBVA will request the delisting of the redeemed shares from the relevant Stock Exchanges and the cancellation of the redeemed shares in the accounting records of "Sociedad de Gestión de los Sistemas de Registro, Compensación y Liquidación de Valores, S.A." (Sociedad Unipersonal) (IBERCLEAR).

 

 

Madrid, 23 December 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCTJBRTMTTTBAA
Date   Source Headline
31st Oct 20197:00 amRNS3Q19 Results Press Release
21st Oct 20195:05 pmRNS3Q19 Results Presentation Announcement
8th Oct 20197:41 amRNSCorporate Transactions
3rd Oct 20197:00 amRNSDividend October 2019
30th Sep 20197:00 amRNSRelevant Information DCN
24th Sep 20198:15 amRNSPre-Stabilisation Notice - BBVA
29th Aug 20197:00 amRNSOffer of securities contingently convertible
28th Aug 20197:00 amRNSPreferred securities contingently convertible
8th Aug 20197:00 amRNSSale of BBVA Paraguay
5th Aug 201912:07 pmRNSPost-Stabilisation Notice - BBVA
31st Jul 20198:18 amRNS2Q19 Results Report
31st Jul 20198:14 amRNS2Q19 Results Presentation
31st Jul 20197:08 amRNS2Q19 Results Press Release
18th Jul 20195:32 pmRNS2Q19 Results Presentation Announcement
4th Jul 20195:19 pmRNSFitch Ratings upgrade
21st Jun 20195:25 pmRNSTransfer of credits rights
12th Jun 20198:03 amRNSPre-Stabilisation Notice - BBVA
29th Apr 20195:24 pmRNSAppointments at the board of Directors
29th Apr 20195:20 pmRNS1Q19 Results Presentation
29th Apr 20195:08 pmRNS1Q19 Results Press Release
29th Apr 20195:06 pmRNS1Q19 Results Report
26th Apr 201910:41 amRNS2018 Audited Financial Statements
25th Apr 201910:48 amRNSPost Stabilisation Notice
17th Apr 201910:48 amRNS1Q19 Results Presentation Announcement
12th Apr 20197:00 amRNSGlobal Medium Term Programme - Venue change
20th Mar 201910:52 amRNSPost Stabilisation Notice - BBVA
20th Mar 20197:00 amRNSIssue of securities convertible into BBVA shares
19th Mar 201910:42 amRNSPre Stabilisation Notice
18th Mar 20193:42 pmRNSPrudential Relevance Report Pillar III in 2018
18th Mar 20193:36 pmRNSResolutions adopted by the AGM
20th Feb 20197:00 amRNSRedemption of Subordinated Notes
15th Feb 20197:00 amRNSCapital Requirements for 2019
13th Feb 20198:02 amRNS2019 AGM Proposed Resolutions
12th Feb 20197:00 amRNSFinal dividend calendar 2018
11th Feb 20196:07 pmRNS2019 Annual General Meeting Call
1st Feb 20197:00 amRNSFinal dividend for 2018
1st Feb 20197:00 amRNS4Q18 Results Presentation
1st Feb 20197:00 amRNS4Q18 Results Report
1st Feb 20197:00 amRNS4Q18 Results Press Release
28th Jan 20195:38 pmRNS4Q18 Results Presentation Announcement
16th Jan 20197:00 amRNSRedemption of securities contingently convertible
16th Jan 20197:00 amRNSRedemption of securities contingently convertible
27th Dec 20187:00 amRNSAgreement with Voyager Investing UK Limited
24th Dec 20187:00 amRNSBBVA gives full effect to its succession plan
21st Dec 20187:00 amRNSSuccession plans for Executive Chairman and CEO
20th Dec 20187:00 amRNSEstrategy automobile financing business in Chile
17th Dec 20181:03 pmRNSPublication of approved ECP Information Memorandum
28th Nov 20185:17 pmRNSComposition of the Board of Directors
5th Nov 20187:00 amRNS2018 Stress Test by European Banking Authority
30th Oct 20187:00 amRNS3Q18 Results Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.